Equities analysts predict that Marchex, Inc. (NASDAQ:MCHX) will post sales of $19.71 million for the current quarter, according to Zacks. Two analysts have made estimates for Marchex’s earnings, with the highest sales estimate coming in at $19.80 million and the lowest estimate coming in at $19.62 million. Marchex posted sales of $22.05 million in the same quarter last year, which suggests a negative year over year growth rate of 10.6%. The firm is expected to issue its next earnings report on Thursday, November 1st.

On average, analysts expect that Marchex will report full year sales of $81.67 million for the current financial year, with estimates ranging from $81.65 million to $81.70 million. For the next year, analysts anticipate that the firm will post sales of $82.52 million per share, with estimates ranging from $81.14 million to $83.90 million. Zacks’ sales averages are a mean average based on a survey of sell-side analysts that follow Marchex.

Marchex (NASDAQ:MCHX) last posted its earnings results on Wednesday, August 1st. The technology company reported ($0.03) earnings per share for the quarter. The firm had revenue of $20.22 million during the quarter, compared to analyst estimates of $19.60 million. Marchex had a negative net margin of 3.35% and a negative return on equity of 3.44%.

Several research analysts have recently commented on MCHX shares. Zacks Investment Research lowered Marchex from a “hold” rating to a “sell” rating in a research report on Thursday, May 10th. Northland Securities started coverage on Marchex in a research report on Tuesday, June 12th. They issued an “outperform” rating for the company.

Marchex stock traded down $0.04 during trading hours on Wednesday, hitting $2.73. The stock had a trading volume of 5,763 shares, compared to its average volume of 47,139. Marchex has a 1-year low of $2.52 and a 1-year high of $3.67.

Several institutional investors and hedge funds have recently modified their holdings of the company. Wells Fargo & Company MN boosted its position in Marchex by 219.1% during the 4th quarter. Wells Fargo & Company MN now owns 31,473 shares of the technology company’s stock valued at $101,000 after purchasing an additional 21,611 shares during the period. Spark Investment Management LLC bought a new stake in shares of Marchex during the first quarter worth $224,000. Deutsche Bank AG grew its stake in shares of Marchex by 30.3% during the fourth quarter. Deutsche Bank AG now owns 174,190 shares of the technology company’s stock worth $562,000 after buying an additional 40,462 shares during the last quarter. Alambic Investment Management L.P. grew its stake in shares of Marchex by 17.8% during the first quarter. Alambic Investment Management L.P. now owns 233,297 shares of the technology company’s stock worth $637,000 after buying an additional 35,329 shares during the last quarter. Finally, Unterberg Capital LLC bought a new stake in shares of Marchex during the first quarter worth $1,365,000. Institutional investors own 55.36% of the company’s stock.

Marchex Company Profile

Marchex, Inc operates as a call analytics company. Its products include Marchex Call Analytics, an analytics technology platform that provides data and insights to measure the performance of mobile, online, and offline advertising for advertisers and small business resellers; and Marchex Speech Analytics delivers actionable operational and advertising insights of inbound calls from consumer's interactions.

Featured Story: Marijuana Stocks

Get a free copy of the Zacks research report on Marchex (MCHX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Marchex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marchex and related companies with MarketBeat.com's FREE daily email newsletter.